Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The influenza hemagglutinin protein stem region is a highly conserved structural domain located at the base (proximal to the membrane) of the HA trimer, anchoring the globular head to the viral membrane. Hemagglutinin, the main surface glycoprotein of influenza A and B viruses, is critical for both viral attachment and membrane fusion during infection. The stem region, formed primarily by sequences from the HA2 subunit, harbors the molecular machinery necessary for fusion of the viral and cellular membranes after receptor-mediated endocytosis and exposure to low pH in the endosome[1][2][4]. This region is less variable than the head, making it the principal target for broadly neutralizing antibodies and the focus of universal influenza vaccine initiatives[1][10]. Broadly neutralizing antibodies, as well as small-molecule inhibitors and engineered binding proteins, can bind to the stem region and prevent the conformational changes required for fusion, thereby blocking viral entry and providing cross-strain protection[3][6][9][10]. Drugs directed at this region are under investigation, and the domain is increasingly recognized as a validated antiviral target.
Inhibition of membrane fusion (by blocking structural rearrangement of the HA stem); Neutralization of viral infectivity by preventing conformational changes necessary for viral entry[3][6][10]; Promotion of antibody-dependent cell-mediated cytotoxicity and complement activation (for antibody drugs)[10]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza hemagglutinin protein stem region (HA stem region).